News

The FDA has expanded the approval of belzutifan (Welireg) to include certain types of pheochromocytoma or paraganglioma (PPGL ...
The U.S. Food and Drug Administration (FDA) has approved HemiClor, a 12.5 mg chlorthalidone tablet developed by PRM Pharma, ...